雜志介紹

Global Heart雜志介紹

《Global Heart》是一(yi)本以(yi)English為主的(de)(de)未(wei)開(kai)放(fang)獲取國際(ji)優秀期刊(kan)，中文名稱全球(qiu)心臟，本刊(kan)主要出版、報道醫學-CARDIAC & CARDIOVASCULAR SYSTEMS領(ling)(ling)域(yu)的(de)(de)研究動(dong)態(tai)以(yi)及在該領(ling)(ling)域(yu)取得的(de)(de)各方面(mian)的(de)(de)經驗(yan)和科研成果，介紹該領(ling)(ling)域(yu)有關本專業(ye)的(de)(de)最新(xin)(xin)進(jin)展(zhan)，探討(tao)行業(ye)發展(zhan)的(de)(de)思路和方法，以(yi)促進(jin)學術信(xin)息交流，提高行業(ye)發展(zhan)。該刊(kan)已被(bei)國際(ji)權威數據庫SCIE收錄，為該領(ling)(ling)域(yu)相關學科的(de)(de)發展(zhan)起到(dao)了(le)良好(hao)的(de)(de)推動(dong)作(zuo)用，也得到(dao)了(le)本專業(ye)人員(yuan)的(de)(de)廣(guang)泛認可(ke)。該刊(kan)最新(xin)(xin)影響因(yin)子為3，最新(xin)(xin)CiteScore 指數為5.7。

英文介紹

Global Heart雜志英文介紹

Global Heart offers a forum for dialogue and education on research, developments, trends, solutions and public health programs related to the prevention and control of cardiovascular diseases (CVDs) worldwide, with a special focus on low- and middle-income countries (LMICs). Manuscripts should address not only the extent or epidemiology of the problem, but also describe interventions to effectively control and prevent CVDs and the underlying factors. The emphasis should be on approaches applicable in settings with limited resources.

Economic evaluations of successful interventions are particularly welcome. We will also consider negative findings if important. While reports of hospital or clinic-based treatments are not excluded, particularly if they have broad implications for cost-effective disease control or prevention, we give priority to papers addressing community-based activities. We encourage submissions on cardiovascular surveillance and health policies, professional education, ethical issues and technological innovations related to prevention.

Global Heart is particularly interested in publishing data from updated national or regional demographic health surveys, World Health Organization or Global Burden of Disease data, large clinical disease databases or registries. Systematic reviews or meta-analyses on globally relevant topics are welcome. We will also consider clinical research that has special relevance to LMICs, e.g. using validated instruments to assess health-related quality-of-life in patients from LMICs, innovative diagnostic-therapeutic applications, real-world effectiveness clinical trials, research methods (innovative methodologic papers, with emphasis on low-cost research methods or novel application of methods in low resource settings), and papers pertaining to cardiovascular health promotion and policy (quantitative evaluation of health programs.